home All News open_in_new Full Article

Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin

Continued strong performance in Reproductive Medicine which exceeded sales of €1 billion for the first time Adstiladrin® (nadofaragene firadenovec-vncg), our novel gene-based therapy for bladder cancer, emerged as a second growth driver following the first full year of U.S. sales Commitment to sustainability highlighted by supply of 1.5 million doses of Carbetocin Ferring (carbetocin, room […]


today 4 w. ago attach_file Sport

attach_file Economics
attach_file Sport
attach_file Politics
attach_file Economics
attach_file Sport
attach_file Other
attach_file Sport


ID: 1974870420
Add Watch Country

arrow_drop_down